# Rochester Network Lead Academic Participating Site

> **NIH NIH UG1** · UNIVERSITY OF ROCHESTER · 2024 · $50,000

## Abstract

PROJECT SUMMARY/ABSTRACT
The University of Rochester, Wilmot Cancer Institute is a health and research institute ideally suited to achieve
the goals of the NCI NCTN as a Lead Academic Site to improve the lives of people with cancer. Our longstanding
activity as U10-funded members of ECOG (1968-2002) and SWOG (2002-2012) as well as our dedication to
NCTN trials over the past 5 years indicate our continued investment in and commitment to clinical and
translational laboratory research in cancer, particularly the development of and accrual to late-phase Cancer
Clinical Trials. In an era where both the biology of cancer and development of novel therapeutic strategies have
become more complex, requiring multidisciplinary teams of investigators and extensive tissue banking and
correlative studies, our translational scientific program and dedication to the NCTN program is critical for ultimate
success.

## Key facts

- **NIH application ID:** 10994749
- **Project number:** 3UG1CA233230-05S1
- **Recipient organization:** UNIVERSITY OF ROCHESTER
- **Principal Investigator:** Paul M Barr
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $50,000
- **Award type:** 3
- **Project period:** 2019-03-07 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10994749

## Citation

> US National Institutes of Health, RePORTER application 10994749, Rochester Network Lead Academic Participating Site (3UG1CA233230-05S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10994749. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*